1097-P: Implementation Science and Pediatric Diabetes-A Scoping Review of the State of the Literature and Guidance for Future Research

Introduction & Objective: Implementation science (IS) offers rigorous methods to increase use of evidence-based practices (EBPs) in standard care. It is unclear how much and what types of IS research have been conducted in pediatric type 1 (T1D) and type 2 diabetes (T2D). The current scoping review aimed to identify IS-focused research in pediatric diabetes, evaluate integration of IS theory, methods, and terminology, and offer guidance to expand implementation research in pediatric diabetes medical, psychosocial, and education care. Methods: Following the JBI guidelines and PRISMA-ScR checklist for scoping reviews, a search of PubMed, Scopus, PsychINFO, Emcare, CINAHL, and Cochrane Trials Register databases was conducted on 1/31/2023 for English language articles and repeated in 11/2023. Identified articles were uploaded into Covidence. Two independent reviewers screened articles and completed data extraction. Results: 156 studies were identified in the initial search, 62 reached full-text review, and 23 were included in analyses. Of the 23 included papers, 19 were published between 2017 and 2023 and 21 focused on T1D. Most studies involved medical EBPs (n=15), whereas fewer focused on psychosocial (n=7) and diabetes education (n=2) EBPs. Most studies (n=11) identified barriers and facilitators of implementing an EBP or were implementation trials (n=11); fewer studies documented gaps in use of an EBP in standard clinical practice (n=7). Only one paper detailed development of an implementation strategy. Five papers employed implementation science theories/models/frameworks. Conclusions: This scoping review identified a young literature examining implementation of EBPs in pediatric diabetes. Few studies employed IS theory and terminology and few described implementation strategies. Guidance for future work to increase use of EBPs across medical, psychosocial, and education care for pediatric diabetes is offered.